Scientific Director, Medical Payer Strategy - Oncology
abbvie
Umowa o pracęPełny etatOpublikowano 8 września 2026
Źródło: About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.
Scientific Director, Medical Payer Strategy - Oncology
- Drives the development and execution of the market access payer, GPO, IDN, guidelines, and clinical pathway scientific strategies within the key Oncology therapeutic areas across all access decision-makers.
- Works cross-functionally in a highly matrixed environment to support scientific and market access needs of brand and market access commercial, HEOR, and medical affairs.
- Represents Medical Payer Strategy (MPS), both internally and externally, as the subject matter expert in translating the scientific and HEOR data with cross-functional stakeholders (Commercial, Market Access, HEOR, Clinical Development, etc).
- Represents V&A Oncology MPS on key cross-functional teams to communicate and integrate medical access evidence needs into the gaps assessment process.
Hybrid model preferred in Lake County IL or Florham Park, NJ
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.
Scientific Director, Medical Payer Strategy - Oncology
- Drives the development and execution of the market access payer, GPO, IDN, guidelines, and clinical pathway scientific strategies within the key Oncology therapeutic areas across all access decision-makers.
- Works cross-functionally in a highly matrixed environment to support scientific and market access needs of brand and market access commercial, HEOR, and medical affairs.
- Represents Medical Payer Strategy (MPS), both internally and externally, as the subject matter expert in translating the scientific and HEOR data with cross-functional stakeholders (Commercial, Market Access, HEOR, Clinical Development, etc).
- Represents V&A Oncology MPS on key cross-functional teams to communicate and integrate medical access evidence needs into the gaps assessment process.
Hybrid model preferred in Lake County IL or Florham Park, NJ
